Megan R Haymart

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. doi request reprint The role of intraoperative frozen section if suspicious for papillary thyroid cancer
    Megan R Haymart
    Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Wisconsin, Madison, Wisconsin 53792, USA
    Thyroid 18:419-23. 2008
  2. doi request reprint Understanding the relationship between age and thyroid cancer
    Megan R Haymart
    Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine and University of Wisconsin Paul P Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI 53792, USA
    Oncologist 14:216-21. 2009
  3. pmc Variation in the management of thyroid cancer
    Megan R Haymart
    Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA
    J Clin Endocrinol Metab 98:2001-8. 2013
  4. pmc The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer
    Megan R Haymart
    Division of Metabolism, Endocrinology, and Diabetes, Department of Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA
    Cancer 119:259-65. 2013
  5. pmc Factors that influence radioactive iodine use for thyroid cancer
    Maria Papaleontiou
    Division of Metabolism, Endocrinology, and Diabetes, Department of Medicine, University of Michigan Health System, University of Michigan, Ann Arbor, Michigan, USA
    Thyroid 23:219-24. 2013
  6. pmc Thyroid hormone replacement in women of reproductive age: is surgeon knowledge related to operative volume?
    Megan R Haymart
    Division of Metabolism, Endocrinology, and Diabetes, Department of Medicine, University of Michigan Health System, Ann Arbor, Michigan 48109, USA
    Thyroid 20:627-31. 2010
  7. pmc Approach to and treatment of thyroid disorders in the elderly
    Maria Papaleontiou
    Division of Metabolism, Endocrinology and Diabetes, Department of Medicine, University of Michigan Health System, Ann Arbor, MI 48105, USA
    Med Clin North Am 96:297-310. 2012
  8. doi request reprint Marginal treatment benefit in anaplastic thyroid cancer
    Megan R Haymart
    Department of Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, Michigan Department of Medicine, Division of Hematology Oncology, University of Michigan, Ann Arbor, Michigan
    Cancer 119:3133-9. 2013
  9. pmc Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells
    David Yu Greenblatt
    Endocrine Surgery Research Laboratories, Department of Surgery, University of Wisconsin, University of Wisconsin Paul P Carbone Comprehensive Cancer Center, Madison, Wisconsin, USA
    Ann Surg 247:1036-40. 2008
  10. pmc Use of radioactive iodine for thyroid cancer
    Megan R Haymart
    Division of Metabolism, Endocrinology, and Diabetes, Department of Medicine, University of Michigan, Ann Arbor, MI 48109, USA
    JAMA 306:721-8. 2011

Collaborators

Detail Information

Publications10

  1. doi request reprint The role of intraoperative frozen section if suspicious for papillary thyroid cancer
    Megan R Haymart
    Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Wisconsin, Madison, Wisconsin 53792, USA
    Thyroid 18:419-23. 2008
    ..However, if there are characteristics of an aspirate suspicious for PTC but not meeting criteria for diagnosis of PTC, the management is less clear...
  2. doi request reprint Understanding the relationship between age and thyroid cancer
    Megan R Haymart
    Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine and University of Wisconsin Paul P Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI 53792, USA
    Oncologist 14:216-21. 2009
    ..It then provides theories for the relationship between advanced age and poor prognosis, in addition to treatment options tailored to age at diagnosis...
  3. pmc Variation in the management of thyroid cancer
    Megan R Haymart
    Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA
    J Clin Endocrinol Metab 98:2001-8. 2013
    ..Little is known about practice patterns in thyroid cancer, a cancer that is increasing in incidence...
  4. pmc The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer
    Megan R Haymart
    Division of Metabolism, Endocrinology, and Diabetes, Department of Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA
    Cancer 119:259-65. 2013
    ....
  5. pmc Factors that influence radioactive iodine use for thyroid cancer
    Maria Papaleontiou
    Division of Metabolism, Endocrinology, and Diabetes, Department of Medicine, University of Michigan Health System, University of Michigan, Ann Arbor, Michigan, USA
    Thyroid 23:219-24. 2013
    ..There is variation in the use of radioactive iodine (RAI) as treatment for well-differentiated thyroid cancer. The factors involved in physician decision-making for RAI remain unknown...
  6. pmc Thyroid hormone replacement in women of reproductive age: is surgeon knowledge related to operative volume?
    Megan R Haymart
    Division of Metabolism, Endocrinology, and Diabetes, Department of Medicine, University of Michigan Health System, Ann Arbor, Michigan 48109, USA
    Thyroid 20:627-31. 2010
    ..The objective of this study was to identify the role of the surgeon in patient education at the time of initiation of LT4 therapy...
  7. pmc Approach to and treatment of thyroid disorders in the elderly
    Maria Papaleontiou
    Division of Metabolism, Endocrinology and Diabetes, Department of Medicine, University of Michigan Health System, Ann Arbor, MI 48105, USA
    Med Clin North Am 96:297-310. 2012
    ..This review focuses on the epidemiology, clinical presentation, risks and complications, and management of thyroid disorders in older adults, including hyperthyroidism, hypothyroidism, thyroid nodules, and thyroid cancer...
  8. doi request reprint Marginal treatment benefit in anaplastic thyroid cancer
    Megan R Haymart
    Department of Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, Michigan Department of Medicine, Division of Hematology Oncology, University of Michigan, Ann Arbor, Michigan
    Cancer 119:3133-9. 2013
    ..Because anaplastic thyroid cancer is a rare malignancy with a high mortality rate, the benefit of multimodality treatment was evaluated...
  9. pmc Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells
    David Yu Greenblatt
    Endocrine Surgery Research Laboratories, Department of Surgery, University of Wisconsin, University of Wisconsin Paul P Carbone Comprehensive Cancer Center, Madison, Wisconsin, USA
    Ann Surg 247:1036-40. 2008
    ..To examine the effects of valproic acid (VPA) on Notch1 expression and cancer cell proliferation in medullary thyroid cancer (MTC) cells...
  10. pmc Use of radioactive iodine for thyroid cancer
    Megan R Haymart
    Division of Metabolism, Endocrinology, and Diabetes, Department of Medicine, University of Michigan, Ann Arbor, MI 48109, USA
    JAMA 306:721-8. 2011
    ..Substantial uncertainty persists about the indications for radioactive iodine for thyroid cancer. Use of radioactive iodine over time and the correlates of its use remain unknown...